111 related articles for article (PubMed ID: 7838531)
1. Elongation and premature termination of transcripts initiated from c-fos and c-myc promoters show dissimilar patterns.
Plet A; Eick D; Blanchard JM
Oncogene; 1995 Jan; 10(2):319-28. PubMed ID: 7838531
[TBL] [Abstract][Full Text] [Related]
2. Regulation of c-fos expression by RNA polymerase elongation competence.
Pinaud S; Mirkovitch J
J Mol Biol; 1998 Jul; 280(5):785-98. PubMed ID: 9671550
[TBL] [Abstract][Full Text] [Related]
3. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
4. Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters.
Kohlhuber F; Strobl LJ; Eick D
Oncogene; 1993 Apr; 8(4):1099-102. PubMed ID: 8455938
[TBL] [Abstract][Full Text] [Related]
5. In vivo footprints between the murine c-myc P1 and P2 promoters.
Plet A; Tourkine N; Mechti N; Jeanteur P; Blanchard JM
Oncogene; 1992 Sep; 7(9):1847-51. PubMed ID: 1501892
[TBL] [Abstract][Full Text] [Related]
6. Changes in promoter utilization in human and mouse c-myc genes upon transformation induction in temperature-sensitive cell lines.
Luo Y; Krause MO
J Cell Physiol; 1994 Aug; 160(2):303-15. PubMed ID: 8040189
[TBL] [Abstract][Full Text] [Related]
7. A protein binding site from the murine c-myc promoter contributes to transcriptional block.
Dufort D; Drolet M; Nepveu A
Oncogene; 1993 Jan; 8(1):165-71. PubMed ID: 8423994
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of c-fos pre-mRNA: contribution of the rates of synthesis and degradation to the copy number of each transcript isoform and detection of a truncated c-Fos immunoreactive species.
Jurado J; Fuentes-Almagro CA; Prieto-Alamo MJ; Pueyo C
BMC Mol Biol; 2007 Sep; 8():83. PubMed ID: 17888145
[TBL] [Abstract][Full Text] [Related]
9. Nucleosome positioning in the human c-Fos promoter analyzed by in vivo footprinting with psoralen and ionizing radiation.
Komura J; Ono T
Biochemistry; 2003 Dec; 42(51):15084-91. PubMed ID: 14690418
[TBL] [Abstract][Full Text] [Related]
10. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
Ben-Yosef T; Yanuka O; Benvenisty N
Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
[TBL] [Abstract][Full Text] [Related]
11. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
12. The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo.
Lavenu A; Pournin S; Babinet C; Morello D
Oncogene; 1994 Feb; 9(2):527-36. PubMed ID: 8290263
[TBL] [Abstract][Full Text] [Related]
13. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
Lutz W; Schwab M
Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
[TBL] [Abstract][Full Text] [Related]
14. Changes in in vivo protein-DNA interactions occur at the c-myc P2 promoter during differentiation.
Bryans M; Lang JC; Wilkie NM
Biochem Biophys Res Commun; 1993 Dec; 197(3):1363-9. PubMed ID: 8280153
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of the Ig kappa gene by promoter-proximal pausing of RNA polymerase II.
Raschke EE; Albert T; Eick D
J Immunol; 1999 Oct; 163(8):4375-82. PubMed ID: 10510378
[TBL] [Abstract][Full Text] [Related]
16. Rapid induction of nuclear transcripts and inhibition of intron decay in response to the polymerase II inhibitor DRB.
Clement JQ; Wilkinson MF
J Mol Biol; 2000 Jun; 299(5):1179-91. PubMed ID: 10873444
[TBL] [Abstract][Full Text] [Related]
17. Distinct properties of c-myc transcriptional elongation are revealed in Xenopus oocytes and mammalian cells and by template titration, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), and promoter mutagenesis.
Meulia T; Krumm A; Groudine M
Mol Cell Biol; 1993 Sep; 13(9):5647-58. PubMed ID: 8355707
[TBL] [Abstract][Full Text] [Related]
18. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
19. Induction of cell death in murine fibroblasts by a c-myc promoter binding protein.
Ray RB
Cell Growth Differ; 1995 Sep; 6(9):1089-96. PubMed ID: 8519685
[TBL] [Abstract][Full Text] [Related]
20. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
Mårtensson UE; Bristulf J; Owman C; Olde B
Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
